In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 26, No. 48 ( 2021-12-02)
Abstract:
Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0–15 years from January 2020 to March 2021. Seropositivity was 1.8–5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.
Type of Medium:
Online Resource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2021.26.48.2101040
Language:
English
Publisher:
European Centre for Disease Control and Prevention (ECDC)
Publication Date:
2021
detail.hit.zdb_id:
2059112-3
Permalink